A.R.T. Advisors, LLC - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 49 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2020$22,000
-75.6%
33,021
-10.5%
0.03%
+560.0%
Q2 2019$90,000
+210.3%
36,891
+86.3%
0.01%
+150.0%
Q4 2018$29,000
-52.5%
19,800
+63.2%
0.00%0.0%
Q1 2018$61,000–12,133–0.00%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders